Harrow, Inc. Fair Value Adjustment of Warrants
Harrow, Inc. (HROW) reported Fair Value Adjustment of Warrants of $982.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-08
- Harrow, Inc. fair value adjustment of warrants for the quarter ending 2017-12-31 was $0.00.
- Harrow, Inc. fair value adjustment of warrants for the quarter ending 2015-12-31 was $0.00.
- Harrow, Inc. fair value adjustment of warrants for the quarter ending 2015-09-30 was $0.00.
- Harrow, Inc. fair value adjustment of warrants for fiscal 2020 was $982.00K, a 0.00% change from fiscal 2019.
- Harrow, Inc. fair value adjustment of warrants for fiscal 2019 was $982.00K, a 0.00% change from fiscal 2018.
- Harrow, Inc. fair value adjustment of warrants for fiscal 2018 was $982.00K, a 0.00% change from fiscal 2017.
- Harrow, Inc. fair value adjustment of warrants for fiscal 2017 was $982.00K.
| Period end | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $982.00K 10-K · filed 2021-03-08 | ||||
| 2019-12-31 | $982.00K 10-K · filed 2020-03-13 | ||||
| 2018-12-31 | $982.00K 10-K · filed 2019-03-12 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $982.00K 10-K · filed 2018-03-08 | |||
| 2017-09-30 | $982.00K 10-Q · filed 2017-11-14 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $0.00 derived: sum of 2 quarters · filed 2017-03-21 | $840.00K 10-K · filed 2017-03-21 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $840.00K 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | $840.00K 10-Q · filed 2016-08-15 | ||||
| 2013-07-31 | $319.79K 10-Q · filed 2013-11-06 | ||||
| 2009-12-31 | $121.45K 10-K · filed 2014-03-28 | ||||
| 2007-09-30 | $550.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |